#116 - Robert Malone MD, Inventor of mRNA & DNA vaccines & Freedom Fighter

Safety Concerns

Dr. Robert Malone shares his concerns about the safety and long-term effects of mRNA vaccines. He recounts his personal experience with adverse reactions after receiving the vaccine, including myopericarditis and hypertension 1. Malone explains the complexities of mRNA immunology and how the immune system might attack cells expressing the spike protein, leading to potential widespread distribution issues 2.

I developed probably myopericarditis. I certainly had hypertension and elevated heart rate. I was life threatening. I had systolic hypertension to 220. I'm now on beta blockers and medically monitored.

--- Dr. Robert Malone

These insights highlight the potential risks associated with mRNA technology and the need for further investigation into its safety.

   

Pharma Ethics

Malone criticizes the pharmaceutical industry's ethical practices, emphasizing the systemic issues that lead to public distrust. He argues that pharma companies exploit regulatory loopholes for profit, compromising safety standards 3. The debate over aluminum adjuvants in vaccines is also discussed, with Malone pointing out their potential toxicity and the industry's slow response to remove them 4.

Pharma is going to do whatever they can to make a profit. And if pharma is going to harm, they will act as they do based on their incentives.

--- Dr. Robert Malone

These ethical concerns underscore the need for stricter regulations and transparency in the pharmaceutical industry.

   

Regulatory Failures

The discussion extends to the failures of regulatory bodies like the FDA in ensuring vaccine safety. Malone highlights the perverse incentives that drive vaccine approval processes, leading to an explosion in the vaccine schedule without adequate safety data 5. He also explains how the vaccine industry manipulates clinical trial data to avoid halting trials due to adverse events 6.

The vaccine industry has created its own kind of ethical logic around the idea that it is unethical to deploy in a clinical trial a vaccine in comparison to a true placebo.

--- Dr. Robert Malone

These regulatory failures call for a reevaluation of the current vaccine approval and monitoring systems.